Subscribe to Regenerative Medicine to read the latest research

Regulatory issues

3D printed products will be regulated differently depending on whether they are a medical device, biological product or pharmaceutical product. Also, as a fast-developing industry, the industry has key regulatory issues that need to be resolved, such as how you keep cells 'clean' during 3D bioprinting; how to prevent black marketing medical printing; and how you ensure traceability, meaning innovation is at risk of outpacing regulation if agencies do not swiftly update their guidance. The channel contains updates and information on the current regulatory environment and global policies as they relate to regulation and safety.